ro glp 1 stock Launches GLP-1 Insurance Coverage Checker Ro Body review: Is this

Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial: The STEP 8 randomized clinical trial

This looks like the first review of weight regain following GLP-1 cessation

The results of a trial of semaglutide in obese patients with HFpEF showed a significant amelioration of symptoms and improvements in motor function and weight loss compared with patients treated with a placebo.470 In this study, researchers randomized 529 patients with heart failure with a preserved ejection fraction and body mass index (weight in kilograms in the square of the height in meters) 30 to receive once-weekly injections of semaglutide (2.4 mg) or placebo for 52 weeks

A January 2025 randomized trial in JAMA Psychiatry found those using low-dose semaglutide to be at a lower risk of hospitalizations related to alcohol use than those who were not using it